{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:36:49Z","timestamp":1793371009681,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bulcan.2026.06.004","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:06:23Z","timestamp":1789592783000},"page":"1293-1302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prise en charge des complications thrombotiques (MTEV) chez l\u2019enfant atteint de leuc\u00e9mie aigu\u00eb lymphoblastique, recommandations des ateliers d\u2019harmonisation du comit\u00e9 leuc\u00e9mie de la Soci\u00e9t\u00e9 fran\u00e7aise de lutte contre les cancers de l\u2019enfant (SFCE)"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7231-7881","authenticated-orcid":false,"given":"Audrey F.","family":"Petit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Voisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Pluchart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Falaise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Leleu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Rabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Leverger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marl\u00e8ne","family":"Pasquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Theron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bulcan.2026.06.004_bib0195","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1182\/asheducation-2018.1.399","article-title":"Management of thrombosis in children and neonates: practical use of anticoagulants in children","volume":"2018","author":"Monagle","year":"2018","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"2","key":"10.1016\/j.bulcan.2026.06.004_bib0200","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/rth2.12182","article-title":"Venous thromboembolism in a large cohort of children with acute lymphoblastic leukemia: risk factors and effect on prognosis","volume":"3","author":"Klaassen","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"issue":"6","key":"10.1016\/j.bulcan.2026.06.004_bib0205","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1160\/TH13-10-0827","article-title":"Epidemiology of venous thrombosis in children with cancer","volume":"111","author":"Piovesan","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bulcan.2026.06.004_bib0210","doi-asserted-by":"crossref","first-page":"107694","DOI":"10.1016\/j.leukres.2025.107694","article-title":"Incidence and risk factors of venous thromboembolism in patients with acute leukemia: a systematic review and meta-analysis","volume":"153","author":"Zhang","year":"2025","journal-title":"Leuk Res"},{"issue":"7","key":"10.1016\/j.bulcan.2026.06.004_bib0215","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1182\/blood-2006-04-015511","article-title":"Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients","volume":"108","author":"Caruso","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2026.06.004_bib0220","article-title":"Thrombosis complications in pediatric acute lymphoblastic leukemia: risk factors, management, and prevention: is there any role for pharmacologic prophylaxis?","volume":"10","author":"Rodriguez","year":"2022","journal-title":"Front Pediatr [Internet]"},{"issue":"4","key":"10.1016\/j.bulcan.2026.06.004_bib0225","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/bjh.14231","article-title":"Cerebral sinovenous thrombosis in children and young adults with acute lymphoblastic leukaemia\u00a0\u2013\u00a0a cohort study from the United Kingdom","volume":"179","author":"Musgrave","year":"2017","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.bulcan.2026.06.004_bib0230","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/ajh.26193","article-title":"Thrombosis is associated with worse survival in children with acute lymphoblastic leukemia: a report from CYP-C","volume":"96","author":"Pelland-Marcotte","year":"2021","journal-title":"Am J Hematol"},{"issue":"02","key":"10.1016\/j.bulcan.2026.06.004_bib0235","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1055\/s-0039-1688412","article-title":"Venous thrombosis in children with acute lymphoblastic leukemia treated on DCOG ALL-9 and ALL-10 protocols: the effect of fresh frozen plasma","volume":"03","author":"Klaassen","year":"2019","journal-title":"TH Open"},{"key":"10.1016\/j.bulcan.2026.06.004_bib0240","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejca.2021.08.025","article-title":"How much asparaginase is needed for optimal outcome in childhood acute lymphoblastic leukaemia? A systematic review","volume":"157","author":"Brigitha","year":"2021","journal-title":"Eur J Cancer"},{"issue":"17","key":"10.1016\/j.bulcan.2026.06.004_bib0245","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1200\/JCO.19.03024","article-title":"Impact of asparaginase discontinuation on outcome in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group","volume":"38","author":"Gupta","year":"2020","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.bulcan.2026.06.004_bib0250","doi-asserted-by":"crossref","first-page":"e29581","DOI":"10.1002\/pbc.29581","article-title":"Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001","volume":"69","author":"Athale","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bulcan.2026.06.004_bib0255","doi-asserted-by":"crossref","first-page":"843643","DOI":"10.3389\/fped.2022.843643","article-title":"Systemic catheter-related venous thromboembolism in children: data from the Italian Registry of Pediatric Thrombosis","volume":"10","author":"Lasagni","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.bulcan.2026.06.004_bib0260","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.thromres.2018.01.019","article-title":"Thrombosis in pediatric patients with leukemia","volume":"164","author":"Levy-Mendelovich","year":"2018","journal-title":"Thromb Res"},{"issue":"5","key":"10.1016\/j.bulcan.2026.06.004_bib0265","doi-asserted-by":"crossref","first-page":"e26938","DOI":"10.1002\/pbc.26938","article-title":"Impact of baseline clinical and laboratory features on the risk of thrombosis in children with acute lymphoblastic leukemia: a prospective evaluation","volume":"65","author":"Athale","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.bulcan.2026.06.004_bib0270","first-page":"197","article-title":"Prescription et r\u00e9alisation d\u2019un bilan biologique \u00e0 la recherche d\u2019une thrombophilie\u00a0: propositions du GFHT 2022 Partie II\u00a0: prescription en cas de thromboses atypiques et lors de situations particuli\u00e8res","volume":"4","author":"Trillot","year":"2022","journal-title":"Rev Francoph H\u00e9most Thromb"},{"issue":"6","key":"10.1016\/j.bulcan.2026.06.004_bib0275","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0022-3476(82)80536-2","article-title":"The effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia","volume":"100","author":"Priest","year":"1982","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.bulcan.2026.06.004_bib0280","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/cncr.11042","volume":"97","author":"Mitchell","year":"2003","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.bulcan.2026.06.004_bib0285","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00001721-200107000-00005","article-title":"Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia","volume":"12","author":"Elhasid","year":"2001","journal-title":"Blood Coagul Fibrinolysis Int J Haemost Thromb"},{"issue":"4","key":"10.1016\/j.bulcan.2026.06.004_bib0290","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.3747\/co.23.3077","article-title":"Venous thromboembolism prevention during asparaginase-based therapy for acute lymphoblastic leukemia","volume":"23","author":"Sibai","year":"2016","journal-title":"Curr Oncol Tor Ont"},{"issue":"10","key":"10.1016\/j.bulcan.2026.06.004_bib0295","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3324\/haematol.12948","article-title":"Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study","volume":"93","author":"Hunault-Berger","year":"2008","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.bulcan.2026.06.004_bib0300","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/pbc.21222","article-title":"Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia","volume":"50","author":"Meister","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.bulcan.2026.06.004_bib0305","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3324\/haematol.2018.194175","article-title":"THROMBOTECT\u00a0\u2013\u00a0a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents","volume":"104","author":"Greiner","year":"2019","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.bulcan.2026.06.004_bib0310","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S2352-3026(19)30219-4","article-title":"Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial","volume":"7","author":"Male","year":"2020","journal-title":"Lancet Haematol"},{"issue":"7","key":"10.1016\/j.bulcan.2026.06.004_bib0315","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1182\/blood.2019000998","article-title":"Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children","volume":"135","author":"Brand\u00e3o","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bulcan.2026.06.004_bib0320","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1016\/S2352-3026(20)30368-9","article-title":"Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b\/3, non-inferiority trial","volume":"8","author":"Halton","year":"2021","journal-title":"Lancet Haematol"},{"issue":"1","key":"10.1016\/j.bulcan.2026.06.004_bib0325","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/S2352-3026(23)00314-9","article-title":"Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial","volume":"11","author":"O\u2019Brien","year":"2024","journal-title":"Lancet Haematol"},{"issue":"29","key":"10.1016\/j.bulcan.2026.06.004_bib0330","doi-asserted-by":"crossref","first-page":"e43370","DOI":"10.1097\/MD.0000000000043370","article-title":"Pediatric thrombosis: risk factors, diagnosis, and prevention strategies","volume":"104","author":"Obeagu","year":"2025","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bulcan.2026.06.004_bib0335","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.thromres.2020.08.016","article-title":"Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: a systematic review","volume":"194","author":"Li","year":"2020","journal-title":"Thromb Res"},{"issue":"12","key":"10.1016\/j.bulcan.2026.06.004_bib0340","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/jth.13856","article-title":"Evaluation of the age-dependent dosing recommendations for the administration of daily tinzaparin in children with thrombosis","volume":"15","author":"Musgrave","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.bulcan.2026.06.004_bib0345","first-page":"223","article-title":"Thromboses veineuses sur cath\u00e9ter central chez l\u2019enfant\u00a0: recommandations du groupe des p\u00e9diatres de la Soci\u00e9t\u00e9 fran\u00e7aise de thrombose et d\u2019h\u00e9mostase (SFTH)","volume":"6","author":"Oudot-Challard","year":"2023","journal-title":"Perfect Pediatr"},{"issue":"4","key":"10.1016\/j.bulcan.2026.06.004_bib0350","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/STR.0b013e31820a8364","article-title":"Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Saposnik","year":"2011","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.bulcan.2026.06.004_bib0355","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.chest.2021.09.019","article-title":"Acute management of high-risk and intermediate-risk pulmonary embolism in children: a review","volume":"161","author":"Ross","year":"2022","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.bulcan.2026.06.004_bib0360","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.2024.12708","article-title":"Perioperative management of patients taking direct oral anticoagulants: a review","volume":"332","author":"Douketis","year":"2024","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.bulcan.2026.06.004_bib0365","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1182\/blood-2018-06-820746","article-title":"Treatment of bleeding complications in patients on anticoagulant therapy","volume":"133","author":"Piran","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2026.06.004_bib0370","doi-asserted-by":"crossref","first-page":"860369","DOI":"10.3389\/fped.2022.860369","article-title":"Practical considerations for use of direct oral anticoagulants in children","volume":"10","author":"Whitworth","year":"2022","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1016\/j.bulcan.2026.06.004_bib0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08880018.2014.960119","article-title":"A practical approach to the use of low molecular weight heparins in VTE treatment and prophylaxis in children and newborns","volume":"32","author":"Molinari","year":"2015","journal-title":"Pediatr Hematol Oncol"},{"issue":"6","key":"10.1016\/j.bulcan.2026.06.004_bib0190","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.pharma.2021.02.007","article-title":"\u00c9noxaparine et tinzaparine en p\u00e9diatrie\u00a0: impact de recommandations sur la qualit\u00e9 des prescriptions et l\u2019activit\u00e9 anti-Xa","volume":"79","author":"Noailly","year":"2021","journal-title":"Ann Pharm Fr"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126003681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126003681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:26:59Z","timestamp":1793370419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455126003681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0007455126003681"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.06.004","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prise en charge des complications thrombotiques (MTEV) chez l\u2019enfant atteint de leuc\u00e9mie aigu\u00eb lymphoblastique, recommandations des ateliers d\u2019harmonisation du comit\u00e9 leuc\u00e9mie de la Soci\u00e9t\u00e9 fran\u00e7aise de lutte contre les cancers de l\u2019enfant (SFCE)","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}